COVID-19 Vaccine Delivery and Distribution Statement From MD Anderson
December 15, 2020
December 15, 2020
HOUSTON, Texas, Dec. 15 -- The University of Texas's MD Anderson Cancer Center issued the following news release:
The University of Texas MD Anderson Cancer Center is prepared to accept, store and distribute the Pfizer COVID-19 vaccine following the Food and Drug Administration's decision on Friday, Dec. 11, to grant Emergency Use Authorization.
At present, state and local health officials have allocated 4,875 doses of vaccine in the first shipment to MD Anderson for us . . .
The University of Texas MD Anderson Cancer Center is prepared to accept, store and distribute the Pfizer COVID-19 vaccine following the Food and Drug Administration's decision on Friday, Dec. 11, to grant Emergency Use Authorization.
At present, state and local health officials have allocated 4,875 doses of vaccine in the first shipment to MD Anderson for us . . .